- Home
- NRIM vs ZVRA Comparison
NRIM vs ZVRA Comparison
Compare NRIM & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRIM
- ZVRA
- Stock Information
- Founded
- NRIM 1990
- ZVRA 2006
- Country
- NRIM United States
- ZVRA United States
- Employees
- NRIM N/A
- ZVRA N/A
- Industry
- NRIM Savings Institutions
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- NRIM Finance
- ZVRA Health Care
- Exchange
- NRIM Nasdaq
- ZVRA Nasdaq
- Market Cap
- NRIM 444.5M
- ZVRA 467.6M
- IPO Year
- NRIM N/A
- ZVRA 2015
- Fundamental
- Price
- NRIM $22.22
- ZVRA $10.12
- Analyst Decision
- NRIM
- ZVRA Strong Buy
- Analyst Count
- NRIM 0
- ZVRA 7
- Target Price
- NRIM N/A
- ZVRA $22.57
- AVG Volume (30 Days)
- NRIM 108.3K
- ZVRA 1.8M
- Earning Date
- NRIM 10-22-2025
- ZVRA 11-05-2025
- Dividend Yield
- NRIM 2.88%
- ZVRA N/A
- EPS Growth
- NRIM 91.41
- ZVRA N/A
- EPS
- NRIM 2.80
- ZVRA N/A
- Revenue
- NRIM $201,544,000.00
- ZVRA $62,020,000.00
- Revenue This Year
- NRIM $11.35
- ZVRA $336.43
- Revenue Next Year
- NRIM $7.32
- ZVRA $54.26
- P/E Ratio
- NRIM $7.92
- ZVRA N/A
- Revenue Growth
- NRIM 42.34
- ZVRA 161.81
- 52 Week Low
- NRIM $15.92
- ZVRA $6.19
- 52 Week High
- NRIM $25.05
- ZVRA $13.16
- Technical
- Relative Strength Index (RSI)
- NRIM 25.56
- ZVRA 47.05
- Support Level
- NRIM $20.70
- ZVRA $10.56
- Resistance Level
- NRIM $21.60
- ZVRA $11.23
- Average True Range (ATR)
- NRIM 0.76
- ZVRA 0.59
- MACD
- NRIM 2.54
- ZVRA -0.09
- Stochastic Oscillator
- NRIM 74.54
- ZVRA 3.05
About NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The Company operates in three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. It generates maximum revenue from the Community Banking segment which offers loan and deposit products to business and consumer customers in its market areas and operates nearly 20 branches throughout Alaska.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.